Watch GENB. Know when insiders buy.
One email the day a filing lands. Free.
Work order
50
WATCH · insiders 49, shorts 50
Insiders, 90 days
−$16K
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
FINANCIALS: NOT YET PULLED FROM SEC XBRL, CHECK BACK AFTER TONIGHT52W 11.21 – 20.38
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $6.3M | — | — | −$71.6M | −$67.3M | — | -0.52 | −$57.9M | $933K | −$58.9M | Aug 6 |
| Q1 2026 · Mar 31 | $7.2M | — | — | −$64.1M | −$61.4M | — | -1.07 | −$80.4M | $3.8M | −$84.2M | Aug 6 |
| Q2 2025 · Jun 30 | $10.1M | — | — | −$60.1M | −$52.4M | — | -1.94 | −$48.8M | $154K | −$48.9M | Aug 6 |
| Q1 2025 · Mar 31 | $8.8M | — | — | −$48.2M | −$41.7M | — | -1.62 | −$53.2M | $751K | −$53.9M | Aug 6 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|
Every number comes from Generate Biomedicines, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.